vs

Side-by-side financial comparison of Mastech Digital, Inc. (MHH) and RIGEL PHARMACEUTICALS INC (RIGL). Click either name above to swap in a different company.

RIGEL PHARMACEUTICALS INC is the larger business by last-quarter revenue ($69.8M vs $45.5M, roughly 1.5× Mastech Digital, Inc.). RIGEL PHARMACEUTICALS INC runs the higher net margin — 384.0% vs 2.1%, a 381.9% gap on every dollar of revenue. On growth, RIGEL PHARMACEUTICALS INC posted the faster year-over-year revenue change (21.2% vs -10.4%). Over the past eight quarters, RIGEL PHARMACEUTICALS INC's revenue compounded faster (53.7% CAGR vs -1.5%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

Rigel Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing targeted small molecule therapies for autoimmune, inflammatory, and hematologic diseases. Its approved flagship product treats adult immune thrombocytopenia, with primary operations and core markets in the United States, addressing unmet medical needs for underserved patient groups.

MHH vs RIGL — Head-to-Head

Bigger by revenue
RIGL
RIGL
1.5× larger
RIGL
$69.8M
$45.5M
MHH
Growing faster (revenue YoY)
RIGL
RIGL
+31.6% gap
RIGL
21.2%
-10.4%
MHH
Higher net margin
RIGL
RIGL
381.9% more per $
RIGL
384.0%
2.1%
MHH
Faster 2-yr revenue CAGR
RIGL
RIGL
Annualised
RIGL
53.7%
-1.5%
MHH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MHH
MHH
RIGL
RIGL
Revenue
$45.5M
$69.8M
Net Profit
$972.0K
$268.1M
Gross Margin
28.3%
91.5%
Operating Margin
2.2%
33.2%
Net Margin
2.1%
384.0%
Revenue YoY
-10.4%
21.2%
Net Profit YoY
227.3%
1769.2%
EPS (diluted)
$0.08
$14.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MHH
MHH
RIGL
RIGL
Q4 25
$45.5M
$69.8M
Q3 25
$48.5M
$69.5M
Q2 25
$49.1M
$101.7M
Q1 25
$48.3M
$53.3M
Q4 24
$50.7M
$57.6M
Q3 24
$51.8M
$55.3M
Q2 24
$49.5M
$36.8M
Q1 24
$46.8M
$29.5M
Net Profit
MHH
MHH
RIGL
RIGL
Q4 25
$972.0K
$268.1M
Q3 25
$941.0K
$27.9M
Q2 25
$135.0K
$59.6M
Q1 25
$-1.4M
$11.4M
Q4 24
$297.0K
$14.3M
Q3 24
$1.9M
$12.4M
Q2 24
$1.4M
$-1.0M
Q1 24
$-161.0K
$-8.2M
Gross Margin
MHH
MHH
RIGL
RIGL
Q4 25
28.3%
91.5%
Q3 25
27.8%
93.2%
Q2 25
28.1%
95.6%
Q1 25
26.7%
91.7%
Q4 24
29.0%
89.9%
Q3 24
28.5%
85.5%
Q2 24
28.2%
92.4%
Q1 24
25.9%
93.1%
Operating Margin
MHH
MHH
RIGL
RIGL
Q4 25
2.2%
33.2%
Q3 25
1.7%
40.9%
Q2 25
0.1%
60.1%
Q1 25
-3.8%
23.9%
Q4 24
0.1%
28.9%
Q3 24
4.7%
25.4%
Q2 24
3.4%
1.2%
Q1 24
-0.9%
-23.6%
Net Margin
MHH
MHH
RIGL
RIGL
Q4 25
2.1%
384.0%
Q3 25
1.9%
40.2%
Q2 25
0.3%
58.6%
Q1 25
-3.0%
21.5%
Q4 24
0.6%
24.9%
Q3 24
3.6%
22.5%
Q2 24
2.8%
-2.8%
Q1 24
-0.3%
-27.9%
EPS (diluted)
MHH
MHH
RIGL
RIGL
Q4 25
$0.08
$14.11
Q3 25
$0.08
$1.46
Q2 25
$0.01
$3.28
Q1 25
$-0.12
$0.63
Q4 24
$0.01
$0.82
Q3 24
$0.16
$0.70
Q2 24
$0.12
$-0.06
Q1 24
$-0.01
$-0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MHH
MHH
RIGL
RIGL
Cash + ST InvestmentsLiquidity on hand
$36.5M
$155.0M
Total DebtLower is stronger
$52.5M
Stockholders' EquityBook value
$89.3M
$391.5M
Total Assets
$111.8M
$513.6M
Debt / EquityLower = less leverage
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MHH
MHH
RIGL
RIGL
Q4 25
$36.5M
$155.0M
Q3 25
$32.7M
$137.1M
Q2 25
$27.9M
$108.4M
Q1 25
$24.7M
$77.1M
Q4 24
$27.7M
$77.3M
Q3 24
$23.9M
$61.1M
Q2 24
$20.6M
$49.1M
Q1 24
$19.4M
$49.5M
Total Debt
MHH
MHH
RIGL
RIGL
Q4 25
$52.5M
Q3 25
$60.0M
Q2 25
$60.0M
Q1 25
$60.0M
Q4 24
$60.0M
Q3 24
$60.0M
Q2 24
$60.0M
Q1 24
$60.0M
Stockholders' Equity
MHH
MHH
RIGL
RIGL
Q4 25
$89.3M
$391.5M
Q3 25
$88.0M
$117.6M
Q2 25
$87.8M
$81.9M
Q1 25
$86.9M
$18.6M
Q4 24
$87.4M
$3.3M
Q3 24
$86.5M
$-14.6M
Q2 24
$84.0M
$-29.9M
Q1 24
$81.7M
$-31.7M
Total Assets
MHH
MHH
RIGL
RIGL
Q4 25
$111.8M
$513.6M
Q3 25
$112.6M
$242.5M
Q2 25
$110.4M
$206.7M
Q1 25
$110.1M
$176.0M
Q4 24
$111.5M
$164.0M
Q3 24
$111.5M
$139.4M
Q2 24
$107.5M
$128.4M
Q1 24
$106.1M
$126.5M
Debt / Equity
MHH
MHH
RIGL
RIGL
Q4 25
0.13×
Q3 25
0.51×
Q2 25
0.73×
Q1 25
3.23×
Q4 24
18.25×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MHH
MHH
RIGL
RIGL
Operating Cash FlowLast quarter
$4.4M
$22.0M
Free Cash FlowOCF − Capex
$4.3M
FCF MarginFCF / Revenue
9.5%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
4.48×
0.08×
TTM Free Cash FlowTrailing 4 quarters
$10.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MHH
MHH
RIGL
RIGL
Q4 25
$4.4M
$22.0M
Q3 25
$6.5M
$24.0M
Q2 25
$3.3M
$30.5M
Q1 25
$-3.0M
$-893.0K
Q4 24
$4.0M
$14.5M
Q3 24
$3.3M
$21.7M
Q2 24
$1.2M
$302.0K
Q1 24
$-1.3M
$-5.0M
Free Cash Flow
MHH
MHH
RIGL
RIGL
Q4 25
$4.3M
Q3 25
$6.3M
Q2 25
$3.2M
Q1 25
$-3.1M
Q4 24
$3.9M
Q3 24
$3.2M
Q2 24
$707.0K
Q1 24
$-1.6M
FCF Margin
MHH
MHH
RIGL
RIGL
Q4 25
9.5%
Q3 25
13.0%
Q2 25
6.6%
Q1 25
-6.4%
Q4 24
7.7%
Q3 24
6.2%
Q2 24
1.4%
Q1 24
-3.4%
Capex Intensity
MHH
MHH
RIGL
RIGL
Q4 25
0.1%
Q3 25
0.4%
Q2 25
0.1%
Q1 25
0.2%
Q4 24
0.2%
Q3 24
0.1%
Q2 24
1.0%
Q1 24
0.6%
Cash Conversion
MHH
MHH
RIGL
RIGL
Q4 25
4.48×
0.08×
Q3 25
6.88×
0.86×
Q2 25
24.41×
0.51×
Q1 25
-0.08×
Q4 24
13.60×
1.01×
Q3 24
1.76×
1.75×
Q2 24
0.85×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MHH
MHH

IT Staffing Services$37.6M83%
Data And Analytics Services$7.8M17%

RIGL
RIGL

Segment breakdown not available.

Related Comparisons